Burning Mouth Syndrome: Advances and Challenges in Pain Control

The management of neuropathic pain in Burning Mouth Syndrome (BMS) remains a formidable clinical challenge, characterized by often suboptimal therapeutic outcomes and a high burden on patient quality of life. This special issue is dedicated to a focused examination of the latest advances, challenges, and future directions specifically in the domain of pain control for BMS. We aim to move the field forward by critically evaluating the transition from empirical, broad-spectrum approaches towards mechanism-based, personalized analgesic strategies.

The scope of this special issue encompasses the entire spectrum of pain control, from foundational research to clinical application. We welcome contributions that investigate novel pharmacological targets, explore the efficacy and mechanisms of non-pharmacological interventions, and analyze the factors governing treatment response heterogeneity. The suggested article types for submission include Original Research and Review articles. A particular emphasis will be placed on studies that seek to identify biomarkers predictive of analgesic success, which is the critical next step for precision medicine in BMS pain management.

We strongly encourage an interdisciplinary approach. Submissions are invited from researchers and clinicians in pain medicine, neurology, oral medicine, pharmacology, and dentistry. By integrating diverse perspectives, this special issue seeks to synthesize a cohesive framework for evidence-based pain control. Our goal is to provide clinicians with a refined, practical understanding of how to effectively alleviate suffering and restore function for individuals living with the chronic pain of BMS. We look forward to your contributions that will help illuminate the path to more effective and targeted pain management solutions.